194 related articles for article (PubMed ID: 34911982)
1. A functional spleen contributes to afucosylated IgG in humans.
Wojcik I; Schmidt DE; de Neef LA; Rab MAE; Meek B; de Weerdt O; Wuhrer M; van der Schoot CE; Zwaginga JJ; de Haas M; Falck D; Vidarsson G
Sci Rep; 2021 Dec; 11(1):24045. PubMed ID: 34911982
[TBL] [Abstract][Full Text] [Related]
2. IgG-Fc glycosylation before and after rituximab treatment in immune thrombocytopenia.
Schmidt DE; de Haan N; Sonneveld ME; Porcelijn L; van der Schoot CE; de Haas M; Zwaginga JJ; Wuhrer M; Vidarsson G
Sci Rep; 2020 Feb; 10(1):3051. PubMed ID: 32080262
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G Fragment Crystallizable Glycosylation After Hematopoietic Stem Cell Transplantation Is Dissimilar to Donor Profiles.
de Haan N; van Tol MJD; Driessen GJ; Wuhrer M; Lankester AC
Front Immunol; 2018; 9():1238. PubMed ID: 29915589
[TBL] [Abstract][Full Text] [Related]
4. Differences in IgG Fc Glycosylation Are Associated with Outcome of Pediatric Meningococcal Sepsis.
de Haan N; Boeddha NP; Ekinci E; Reiding KR; Emonts M; Hazelzet JA; Wuhrer M; Driessen GJ
mBio; 2018 Jun; 9(3):. PubMed ID: 29921663
[TBL] [Abstract][Full Text] [Related]
5. Conserved FcγR- glycan discriminates between fucosylated and afucosylated IgG in humans and mice.
Dekkers G; Bentlage AEH; Plomp R; Visser R; Koeleman CAM; Beentjes A; Mok JY; van Esch WJE; Wuhrer M; Rispens T; Vidarsson G
Mol Immunol; 2018 Feb; 94():54-60. PubMed ID: 29268168
[TBL] [Abstract][Full Text] [Related]
6. Changes in Healthy Human IgG Fc-Glycosylation after Birth and during Early Childhood.
de Haan N; Reiding KR; Driessen G; van der Burg M; Wuhrer M
J Proteome Res; 2016 Jun; 15(6):1853-61. PubMed ID: 27161864
[TBL] [Abstract][Full Text] [Related]
7. The "less-is-more" in therapeutic antibodies: Afucosylated anti-cancer antibodies with enhanced antibody-dependent cellular cytotoxicity.
Pereira NA; Chan KF; Lin PC; Song Z
MAbs; 2018 Jul; 10(5):693-711. PubMed ID: 29733746
[TBL] [Abstract][Full Text] [Related]
8. Unique patterns of glycosylation in immunoglobulin subclass G4-related disease and primary sclerosing cholangitis.
Culver EL; van de Bovenkamp FS; Derksen NIL; Koers J; Cargill T; Barnes E; de Neef LA; Koeleman CAM; Aalberse RC; Wuhrer M; Rispens T
J Gastroenterol Hepatol; 2019 Oct; 34(10):1878-1886. PubMed ID: 30345709
[TBL] [Abstract][Full Text] [Related]
9. Unique carbohydrate-carbohydrate interactions are required for high affinity binding between FcgammaRIII and antibodies lacking core fucose.
Ferrara C; Grau S; Jäger C; Sondermann P; Brünker P; Waldhauer I; Hennig M; Ruf A; Rufer AC; Stihle M; Umaña P; Benz J
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12669-74. PubMed ID: 21768335
[TBL] [Abstract][Full Text] [Related]
10. Functional diversification of IgGs through Fc glycosylation.
Wang TT; Ravetch JV
J Clin Invest; 2019 Sep; 129(9):3492-3498. PubMed ID: 31478910
[TBL] [Abstract][Full Text] [Related]
11. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
Fernandes-Cerqueira C; Renard N; Notarnicola A; Wigren E; Gräslund S; Zubarev RA; Lundberg IE; Lundström SL
Sci Rep; 2018 Dec; 8(1):17958. PubMed ID: 30560888
[TBL] [Abstract][Full Text] [Related]
12. Patients with IgG1-anti-red blood cell autoantibodies show aberrant Fc-glycosylation.
Sonneveld ME; de Haas M; Koeleman C; de Haan N; Zeerleder SS; Ligthart PC; Wuhrer M; van der Schoot CE; Vidarsson G
Sci Rep; 2017 Aug; 7(1):8187. PubMed ID: 28811589
[TBL] [Abstract][Full Text] [Related]
13. IgG fc N-glycosylation changes in Lambert-Eaton myasthenic syndrome and myasthenia gravis.
Selman MH; Niks EH; Titulaer MJ; Verschuuren JJ; Wuhrer M; Deelder AM
J Proteome Res; 2011 Jan; 10(1):143-52. PubMed ID: 20672848
[TBL] [Abstract][Full Text] [Related]
14. GlYcoLISA: antigen-specific and subclass-specific IgG Fc glycosylation analysis based on an immunosorbent assay with an LC-MS readout.
Falck D; Wuhrer M
Nat Protoc; 2024 Jun; 19(6):1887-1909. PubMed ID: 38383719
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
16. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
Larsen MD; de Graaf EL; Sonneveld ME; Plomp HR; Nouta J; Hoepel W; Chen HJ; Linty F; Visser R; Brinkhaus M; Šuštić T; de Taeye SW; Bentlage AEH; Toivonen S; Koeleman CAM; Sainio S; Kootstra NA; Brouwer PJM; Geyer CE; Derksen NIL; Wolbink G; de Winther M; Sanders RW; van Gils MJ; de Bruin S; Vlaar APJ; ; ; Rispens T; den Dunnen J; Zaaijer HL; Wuhrer M; Ellen van der Schoot C; Vidarsson G
Science; 2021 Feb; 371(6532):. PubMed ID: 33361116
[TBL] [Abstract][Full Text] [Related]
17. Antibody Fucosylation Lowers the FcγRIIIa/CD16a Affinity by Limiting the Conformations Sampled by the N162-Glycan.
Falconer DJ; Subedi GP; Marcella AM; Barb AW
ACS Chem Biol; 2018 Aug; 13(8):2179-2189. PubMed ID: 30016589
[TBL] [Abstract][Full Text] [Related]
18. MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc
Sénard T; Gargano AFG; Falck D; de Taeye SW; Rispens T; Vidarsson G; Wuhrer M; Somsen GW; Domínguez-Vega E
Front Immunol; 2020; 11():2049. PubMed ID: 32973813
[TBL] [Abstract][Full Text] [Related]
19. The Elements Steering Pathogenesis in IgG-Mediated Alloimmune Diseases.
Sonneveld ME; van der Schoot CE; Vidarsson G
J Clin Immunol; 2016 May; 36 Suppl 1():76-81. PubMed ID: 26961360
[TBL] [Abstract][Full Text] [Related]
20. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
Blundell P; Pleass R
Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
